This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Today's Market Primer: Greece News Is the Driver

Stocks in this article: DNDN NDRO GSK

NEW YORK ( TheStreet) -- News from Europe, particularly Greece, is driving the market Thursday.

The uncertainty about debt-laden Greece has ruled the headlines for months now, and the nervousness about a potential default hasn't subsided. But U.S. stock futures were rising slightly after European leaders put their foot down, saying a plan in Greece to hold a referendum on the European bailout plan would determine whether Greece remains a part of the eurozone. Voting on the referendum is expected to take early next month.

European stocks turned higher after posting losses earlier in the day on word of an emergency cabinet meeting in Greece.






European leaders are holding another round of emergency meetings about Greece on Thursday. President Obama, in France for the G20 summit, stressed the importance of reaching a resolution on the financial crisis in Europe.

"We're going to have to flesh out more of the details about how the plan will be fully and decisively implemented," Obama said.

Obama didn't say what the U.S. might do to help European officials solve the crisis in Greece.






Occupy Wall Street protesters shut down the Port of Oakland, the nation's fifth-busiest shipping port, late Wednesday.

Reports said protestors and the police clashed downtown early Thursday following Wednesday's largely peaceful protests throughout Oakland.

The Occupy Wall Street movement began in New York in September.






GlaxoSmithKline (GSK) agreed in principle with the U.S. government on a $3 billion settlement of investigations over the U.K. drugmaker's sales and marketing practices.

The agreement is expected to be completed in 2012. GlaxoSmithKline said the settlement would be paid through its cash resources.

The case includes a Department of Justice investigation into the marketing of GlaxoSmithKline's diabetes drug Avandia.






Expect Dendreon (DNDN) to open sharply lower Thursday following a disappointing third-quarter earnings report in which management forecast lower Provenge sales for the rest of the year.

Provenge sales totaled $64 million in the September quarter, slightly ahead of consensus, but higher-than-expected costs plus a lackluster outlook for the fourth quarter sent Dendreon shares down as much as 22% in after-hours trading.


Enduro Royalty 's (NDRO) initial public offering priced at $22 on Wednesday, below the expected range of $23-25.

-- Written by Joseph Woelfel



>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs